XML 163 R143.htm IDEA: XBRL DOCUMENT v3.6.0.2
Parent Company Financial Statements (Schedule Of Condensed Statements Of Cash Flows) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]                      
Net income $ 69,275 $ 61,809 $ 54,287 $ 47,569 $ 63,019 $ 57,607 $ 54,784 $ 47,129 $ 232,940 $ 222,539 $ 147,658
Depreciation, amortization and accretion                 59,256 51,593 39,209
Change in fair value of junior subordinated debentures                 6,752 6,163 5,849
Net decrease (increase) in other assets                 (27,080) 24,692 (49,165)
Net decrease in other liabilities                 11,622 15,290 38,632
Net cash provided by operating activities                 421,643 376,740 357,570
Net cash (used) provided by investing activities                 (919,040) (1,756,911) 242,140
Dividends paid on common stock                 (141,074) (134,618) (99,233)
Stock repurchased                 (17,708) (14,589) (7,183)
Proceeds from exercise of stock options                 2,626 1,481 9,368
Net cash provided by financing activities                 1,173,104 548,725 215,038
Net (decrease) increase in cash and cash equivalents                 675,707 (831,446) 814,748
Cash and cash equivalents, beginning of year       773,725       1,605,171 773,725 1,605,171 790,423
Cash and cash equivalents, end of year 1,449,432       773,725       1,449,432 773,725 1,605,171
Umpqua Bank                      
Condensed Financial Statements, Captions [Line Items]                      
Net income                 232,940 222,539 147,658
Equity in undistributed earnings of subsidiaries                 (84,191) (84,116) 91,831
Depreciation, amortization and accretion                 (322) (322) (322)
Change in fair value of junior subordinated debentures                 6,752 6,163 5,849
Net decrease (increase) in other assets                 972 617 (6,020)
Net decrease in other liabilities                 (2,112) (2,903) (8,708)
Net cash provided by operating activities                 154,039 141,978 230,288
Change in subsidiaries                 3,258 (5,000) 6
Acquisitions                 0 0 (102,143)
Net cash (used) provided by investing activities                 3,258 (5,000) (102,137)
Net increase (decrease) in payables to subsidiaries                 45 0 (4)
Dividends paid on common stock                 (141,074) (134,618) (99,233)
Stock repurchased                 (17,708) (14,589) (7,183)
Proceeds from exercise of stock options                 2,626 1,481 7,692
Net cash provided by financing activities                 (156,111) (147,726) (98,728)
Net (decrease) increase in cash and cash equivalents                 1,186 (10,748) 29,423
Cash and cash equivalents, beginning of year       $ 91,354       $ 102,102 91,354 102,102 72,679
Cash and cash equivalents, end of year $ 92,540       $ 91,354       $ 92,540 $ 91,354 $ 102,102